Pirtobrutinib, a Highly Selective, Non-Covalent (reversible) BTK Inhibitor in Patients with B-cell Malignancies: Analysis of the Richter Transformation Subgroup from the Multicentre, Open-Label, Phase 1/2 BRUIN StudyWilliam G. Wierda, Nirav N. Shah, Chan Y. Cheah,David Lewis, Marc S. Hoffmann, Catherine C. Coombs, Nicole Lamanna,Shuo Ma,Deepa Jagadeesh,Talha Munir,Yucai Wang, Toby A. Eyre, Joanna M. Rhodes,Matthew McKinney, Ewa Lech-Maranda,Constantine S. Tam,Wojciech Jurczak,Koji Izutsu, Alvaro J. Alencar, Manish R. Patel,John F. Seymour, Jennifer A. Woyach,Philip A. Thompson,Paolo B. Abada, Caleb Ho, Samuel C. McNeely, Narasimha Marella, Bastien Nguyen, Chunxiao Wang, Amy S. Ruppert,Binoj Nair, Hui Liu, Donald E. Tsai,Lindsey E. Roeker, Paolo GhiaLANCET HAEMATOLOGY（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
